Related Experiment Video

Updated: May 19, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV

Jamal Sarvari1, Zahra Mojtahedi, Yasuhiro Kuramitsu

  • 1Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.

Oncology Letters
|August 7, 2012
PubMed

Insights

Researchers identified key serum proteins that change with hepatitis B virus (HBV) complications like chronic active hepatitis (CAH), cirrhosis, and hepatocellular carcinoma (HCC). Haptoglobin isoforms showed significant differences, potentially serving as biomarkers for these liver diseases.

Area of Science:

  • Hepatology
  • Proteomics
  • Biomarker Discovery

Background:

  • Hepatitis B virus (HBV) infection can lead to severe liver complications including chronic active hepatitis (CAH), liver cirrhosis, and hepatocellular carcinoma (HCC).
  • Identifying specific biomarkers is crucial for early diagnosis, prognosis assessment, and guiding treatment strategies for HBV-related liver diseases.

Purpose of the Study:

  • To identify differentially expressed serum proteins in patients with HBV infection across different stages of liver disease: CAH, cirrhosis, and HCC.
  • To explore the potential of these identified proteins as diagnostic or prognostic biomarkers for HBV-induced liver complications.

Main Methods:

  • Serum samples from patients with HBV-related CAH, cirrhosis, HCC, and healthy controls were analyzed.
  • Proteomic analysis was performed using two-dimensional polyacrylamide gel electrophoresis (2DE) coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS).
  • Statistical analysis was applied to identify differentially expressed protein spots (≥1.5-fold change, p<0.05).

Main Results:

  • A total of 54 differentially expressed protein spots were detected, with 35 identified by LC-MS/MS, corresponding to 13 unique proteins.
  • Key identified proteins include haptoglobin (α-2 and β isoforms), retinol-binding protein, transthyretin, ficolin, leucine-rich-α-2-glycoprotein, α-1-antitrypsin, and clusterin.
  • Notably, haptoglobin α-2 isoforms were significantly increased in HCC patients compared to cirrhosis patients, while a significant decrease was observed in cirrhosis patients.

Conclusions:

  • The study successfully identified several differentially expressed serum proteins associated with HBV-related liver complications.
  • Haptoglobin α-2 isoforms show promise as potential biomarkers, with distinct expression patterns differentiating HCC from cirrhosis.
  • These findings contribute to the understanding of HBV pathogenesis and may aid in developing novel diagnostic and prognostic tools.

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...